Showing results (31-40 of 99) with videos related to

Sort By:
Pageof 10
Current Opinion in Molecular Therapeutics|October 8, 2004
Gene-directed enzyme prodrug therapy: a current assessmentStephanie R McKeown, Claire Ward, Tracy Robson
Cells|June 25, 2020
Top Notch Targeting Strategies in Cancer: A Detailed Overview of Recent Insights and Current PerspectivesGillian Moore, Stephanie Annett, Lana McClements, et al.
Current Molecular Pharmacology|May 20, 2015
The Role of Peptidyl Prolyl Isomerases in Aging and Vascular DiseasesLana McClements, Stephanie Annett, Anita Yakkundi, et al.
Pharmacology Research & Perspectives|March 15, 2022
Dexamethasone promotes breast cancer stem cells in obese and not lean miceStephanie Annett, Orla Willis Fox, Damir Vareslija, et al.
Cancers|November 27, 2021
Characterizing and Exploiting Tumor Microenvironments to Optimize Treatment OutcomesEmma H Allott, Kellie Dean, Tracy Robson, et al.
Molecular Carcinogenesis|November 13, 2009
Cytochrome P450 1B1 mRNA untranslated regions interact to inhibit protein translationAndrea H Devlin, Paul Thompson, Tracy Robson, et al.
International Journal of Molecular Sciences|April 30, 2021
The Cancer Stem Cell Niche in Ovarian Cancer and Its Impact on Immune SurveillanceSrishti Jain, Stephanie L Annett, Maria P Morgan, et al.
Regulatory Peptides|July 17, 2004
The smooth muscle pharmacology of maximakinin, a receptor-selective, bradykinin-related nonadecapeptide from the venom of the Chinese toad, Bombina maximaMartin O'Rourke, Tianbao Chen, David G Hirst, et al.
Cancers|April 30, 2021
Prognostic Significance of Glucocorticoid Receptor Expression in Cancer: A Systematic Review and Meta-AnalysisNoor Bakour, Frank Moriarty, Gillian Moore, et al.
Frontiers in Endocrinology|June 26, 2023
Obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma: current status and therapeutic targetsYinshuang Chen, Weipeng Wang, Maria P Morgan, et al.
Pageof 10